News from jhl biotech A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

27 Dec, 2018, 20:00 GMT JHL Biotech Announces First Patient Randomized in the Phase III Study of JHL1101 to Treat Diffuse Large B-Cell Lymphoma

JHL Biotech announced today that the first patient at Beijing Cancer Hospital has been successfully randomized in the Phase III study of JHL1101 to...


15 Oct, 2018, 14:00 BST JHL Biotech Announces China Approves Phase I and Phase III Clinical Trial Application for Bevacizumab Biosimilar to Treat Cancer

JHL Biotech announced today that the National Medical Products Administration of the PRC (NMPA) has approved JHL's Phase I and Phase III Clinical...


10 Aug, 2018, 02:32 BST JHL Biotech Receives Positive CHMP Scientific Advice for Global Phase III Clinical Trial of Proposed Trastuzumab Biosimilar to Treat Breast Cancer

JHL Biotech has announced it received a positive Scientific Advice from the Committee for Medicinal Products for Human Use (CHMP) of the European...


10 Aug, 2018, 02:24 BST JHL Biotech Receives Positive CHMP Scientific Advice for Global Phase III Clinical Trial of Proposed Bevacizumab Biosimilar to Treat Lung Cancer

JHL Biotech has announced it received a positive Scientific Advice from the Committee for Medicinal Products for Human Use (CHMP) of the European...


09 Jul, 2018, 18:30 BST JHL Biotech Receives Positive CHMP Scientific Advice for Global Phase III Clinical Trial of Proposed Rituximab Biosimilar

JHL Biotech has announced it received a positive Scientific Advice from the Committee for Medicinal Products for Human Use (CHMP) of the European...


05 Jul, 2018, 22:05 BST JHL Biotech Announces China Approves Clinical Trial Rituximab Biosimilar to Treat Non-Hodgkin Lymphoma

JHL Biotech announced today that the Center for Drug Evaluation (CDE), State Drug Administration of China (SDA) has approved JHL's Phase I and Phase...


13 Jun, 2018, 21:25 BST JHL Biotech Announces Completion of Convertible Bond Issuance and Appointment of New Chief Financial Officer

JHL Biotech has raised US$106 million in a convertible bond issuance, which closed May 15, 2018. Proceeds raised from the issuance will be used for...


20 Dec, 2017, 18:29 GMT JHL Biotech Submits Clinical Trial Application in Europe for Proposed Dornase Alfa Biosimilar to Affordably Manage Symptoms of Cystic Fibrosis

JHL Biotech (Stock Code: 6540.TWO) announced today that it has submitted a Phase 1 Clinical Trial Application to the Dutch Healthcare Authority for...


20 Dec, 2017, 15:35 GMT JHL Biotech Submits Clinical Trial Application in Europe for Proposed Bevacizumab Biosimilar to Treat Colorectal, Lung, and Ovarian Cancers

JHL Biotech Inc. (Stock Code: 6540.TWO) announced that it submitted a Phase I Clinical Trial Application on December 15, 2017 to European authorities ...


29 Mar, 2017, 08:05 BST JHL Doses First Patient In JHL1101 Phase I European Trial

JHL Biotech Inc. (Stock Code: 6540.TWO) today announced that the first patient has been dosed in the company's Phase I clinical trial of JHL1101 (a...


20 Oct, 2015, 09:00 BST JHL Biotech Appoints New Leaders to Management Team

JHL Biotech (TWEM: 6540), an emerging biosimilars company in Taiwan and China, announced today that Max Chan will join the company as Chief Financial ...


02 Oct, 2015, 18:26 BST JHL Biotech Lists on the Taiwan Emerging Stock Board

JHL Biotech (TWEM: 6540), an emerging biosimilars company incorporated in Cayman Islands and based in Taiwan and China, announced today it has been...


28 Sep, 2015, 19:13 BST CORRECTED--JHL Biotech Hosts Prominent Brazilian Delegation in Taiwan to Advance Biosimilar Collaborations--CORRECTED

JHL Biotech, an emerging biosimilars company in Taiwan, hosted a delegation of Brazilian government officials and top-ranking biotech executives who...


18 Sep, 2015, 19:00 BST JHL Biotech Hosts Prominent Brazilian Delegation in Taiwan to Advance Biosimilar Collaborations

JHL Biotech, an emerging biosimilars company in Taiwan, hosted a delegation of Brazilian government officials and top-ranking biotech executives who...